To save lives by dramatically reducing
When my son, Pierce, was diagnosed with Acute Myeloid Leukemia in 2017, I wanted to understand as much relevant information as possible.
I wanted to be equipped with the right tools to manage my own grieving process and to help support him.
I wanted more than google, Facebook, and a stack of papers by advocacy organizations. I also wanted to acknowledge the patients and researchers before him, whom I credit his survivorship, and I wanted to help patients after him.
I founded Rabble Health so that more patients and caregivers are equipped with timely resources and tools to understand, advocate, commit, and help others.
Passionate to offer a patient-centric, data driven healthcare solution built on empathetic user experience and responsible AI - all designed to improve outcomes and make healthcare conform to patients.
There is a better way to align incentives and help people with complex disease navigate the seemingly impossible.
Helping patients and their families get support and feel empowered during health crises that upend their lives, and building this support at scale.
The day when each person/family diagnosed with cancer has a personal navigator has arrived. Rabble Health’s innovative solutions serve people at their most vulnerable times.
The bringing together of people, process, information, and technology excites me. Providing a platform for support, bringing relevant information to the forefront, and empowering individuals at a critical time are urgent needs and I am looking forward to being part of this journey.
Cancer patients get their diagnosis from out of the blue and need to get educated, navigate, and find community to help them with decisions about their disease.
J. Michael Sprafka
Open for Business
Started under the name of Monarch Healthcare Management.
Broke ground on technology in June.
Transformed to Rabble Health
Doh! Monarch trademark was denied; we pivoted to become Rabble, a swarm of butterflies.
Corporate site release!
First appearance of our site during Clinical Pathways Congress 2020.